Events

Upcoming Events

The Exact Sciences Medical Affairs team will be hosting the following events:

  • None at this time

Upcoming Congresses

The Exact Sciences Medical Affairs team will be in attendance at the following  

  • DDW: Digestive Disease Week, (May 6 – May 9, 2023), Chicago, IL
    •   Abstracts present:
      • Impact of surveillance and social determinants of health on treatment receipt and healthcare costs in patients with HCC; Session #4460, Podium Presentation #730
      • Cost-effectiveness of Hepatocellular Carcinoma Surveillance Programs Using Multi-Target Blood Test; Session #9215, Poster #Tu1551
      • Cost-effectiveness of stool-based colorectal cancer screening programs from a health system perspective; Session #9045, Poster #Tu1117
      • Estimated impact of adenoma and colorectal cancer early detection on health outcomes and screening effectiveness; Session #9045, Poster #Tu1116
      • Trends in colorectal cancer screening adherence and modality utilization at a large tertiary care center; Session #6000, Poster #Sa1005
      • Trends in follow-up colonoscopy completion after a positive stool-based screening test for colorectal cancer at a large health care system; Session #6000, Poster #Sa1006
      • Estimated adenoma sensitivity threshold needed for blood-based colorectal cancer screening tests to be as effective as stool-based screening tests; Session #9045, Poster #Tu1114
      • Colorectal cancer screening with blood-based tests: Estimated impact of a 1-, 2-, or 3-year screening interval on benefits and harms compared with annual FIT and triennial mt-sDNA strategies; Session #9045, Poster #Tu1113
      • Estimated value-based pricing for Guardant Health Shield blood-based colorectal cancer screening test versus multi-target stool DNA test; Session #9045, Poster #Tu1115
  • ISPOR International 2023, (May 7 – May 10, 2023), Boston, MA
    •  Abstracts present:
      • The large hidden prevalence rate of cancer using backward induction method reveals screening opportunity in earlier stages; Session #5, Poster #EPH232
      • Validating a Machine-Learning Approach to Cancer Stage Identification Using Medicare Claims and SEER Data; Session #2, Poster #MSR32
      • Barriers to In-person Focus Group Participation During the Third-Year of COVID-19 Pandemic: A Case Study of Colorectal Cancer (CRC) Screening in Underrepresented Groups; Session #1, Poster #EPH26
      • Cost of Liver Cancer Screening in Patients with Cirrhosis; Session #5, Poster #EPH217
      • Cost-effectiveness of Profile Omission of Local Adjuvant Radiotherapy (POLAR), a Novel Genomic Signature, after Breast Conserving Surgery for Women with Invasive Early-Stage Breast Cancer (ESBC); Session #3, Poster #EE269
      • Cost Impact of Next Generation Sequencing Testing in NSCLC With and Without RNA Sequencing; Session #3, Poster #EE321
      • Value of Next Generation Sequencing (NGS) Using the OncoExTra Test in Advanced Cancer Patients; Session #4, Poster #EE385
  • AAPA: American Academy of Physician Assistants Conference, (May 20 – May 24, 2023), Nashville, TN
  • ASCO: American Society of Clinical Oncology Annual Meeting, (June 2 – June 6, 2023), Chicago, IL
    •   Abstracts present:
      • Outcomes in participants with false positive multi-cancer early detection (MCED) test: Results from >4 years follow-up from DETECT-A, the first large, prospective, interventional MCED study; Poster board# 237; Abstract # 3039
      • Long-term clinical outcomes of cancers diagnosed following detection by a blood-based multi-cancer early detection (MCED) test; Poster board# 235; Abstract # 3037
      • Unobserved Incidence of Cancer in Earlier Stages is Substantially Higher Than the Observed Incidence; Poster board# 267; Abstract # 10634
      • The detection of multiple cancer types with an extended set of methylation protein markers; Poster board# 238; Abstract # 3040
      • The impact of extending CRC screening to the older population - results from CRC-AIM; Poster board# 200; Abstract # 10567
      • Estimated life-years gained and resultant cost savings from follow-up colonoscopy after positive mt-sDNA for CRC screening in commercially insured Medicare population; Poster board# 134; Abstract # 6642
      • Colorectal cancer screening with blood-based tests: Estimated impact of a 1-, 2-, or 3-year screening interval compared with annual FIT and triennial mt-sDNA strategies; Poster board# 213; Abstract # 10580
      • Estimated value-based pricing for blood-based colorectal cancer screening test versus multi-target stool DNA test; Online publication # e18911
      • Patient-Provider Communication Factors Associated with mt-sDNA Screening for Colorectal Cancer; Online publication # e22514
      • A flexible quantitative framework to assess the potential contribution of early cancer detection to improved cancer survival; Online publication #e22508
      • Validating the Use of Machine-Learning Cancer Staging Algorithms for Medicare Cost Analysis; Online publication #e13548
  • AANP: American Association of Nurse Practitioners National Conference, (June 20 – June 25, 2023), New Orleans, LA
  • Southeastern Colorectal Cancer Consortium Conference, (June 21 – June 23, 2023), Norfolk, VA